Viatris Inc. (VTRS) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Viatris (VTRS) Q1 2026: Greater China Surges 18%, E-Commerce and Pipeline Propel Growth Narrative
May 07, 2026
-
Viatris (VTRS) Q4 2025: $650M Cost Overhaul Sets Stage for Sustainable Margin Expansion
February 26, 2026
-
Viatris (VTRS) Q3 2025: $920M Capital Return Signals Strategic Cost Review and Pipeline Transition
November 06, 2025
-
Viatris (VTRS) Q2 2025: $350M Buybacks Signal Commitment to Shareholder Returns Amid Pipeline Momentum
August 07, 2025
-
Viatris (VTRS) Q1 2025: $2.9B Goodwill Impairment Underscores Volatility, Pipeline and Buybacks Counterbalance Headwinds
July 07, 2025